IntellaMap Orion High Resolution Mapping Catheter; Material number: M004RC64S0; Catalog number R...
FDA Device Recall #Z-0580-2015 — Class II — November 20, 2014
Recall Summary
| Recall Number | Z-0580-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 20, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Boston Scientific Corp |
| Location | San Jose, CA |
| Product Type | Devices |
| Quantity | 184 units |
Product Description
IntellaMap Orion High Resolution Mapping Catheter; Material number: M004RC64S0; Catalog number RC64S; Is indicated for electrophysiological mapping (recording or stimulating only) of the cardiac structures of the heart.
Reason for Recall
Some IntellaMap Orion High Resolution Mapping Catheters are exhibiting a failure mode in which a glue bond on the Deployment Interlock Button has been observed to fail in the field.
Distribution Pattern
Worldwide Distribution -- US, including the states of MA, AL, NC, and OK; and, the countries of Germany, France, and Great Britain.
Lot / Code Information
Lot numbers: 17075550, 17075981, 17083913, 17088826, 17094081, 17101668, 17208445, 17218467, 17251661, 17258617, 17274937, 17292792, and 17308586. Expiry Dates from June 25, 2015 to September 24, 2015.
Other Recalls from Boston Scientific Corp
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0464-2016 | Class II | IntellaTip MiFi XP Asymmetric (N4) Curve 7/110... | Nov 20, 2015 |
| Z-0465-2016 | Class II | IntellaTip MiFi XP Asymmetric (N4) Curve 7/110... | Nov 20, 2015 |
| Z-0462-2016 | Class II | IntellaTip MiFi XP Asymmetric (N4) Curve, 7/11... | Nov 20, 2015 |
| Z-0463-2016 | Class II | IntellaTip MiFi XP Asymmetric (N4) Curve 7/110... | Nov 20, 2015 |
| Z-0402-2016 | Class II | One Step Button, Low Profile Initial Placement ... | Sep 11, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.